New study: specific immune targets in chemotherapy-resistant breast cancer
ADC评论
October 18, 2022
On October 14, a study titled “Dynamic Changes in the NK-, Neutrophil-, and B-cell Immunophenotypes Relevant in High Metastatic Risk Post Neoadjuvant Chemotherapy–Resistant Early Breast
